Protara Therapeutics (TARA) Assets (2013 - 2026)

Protara Therapeutics' Assets history runs 14 years deep, the most recent figure standing at $191.9 million for Q1 2026.

• In Q1 2026, Assets rose 13.86% year-over-year to $191.9 million; the TTM figure through Mar 2026 stood at $191.9 million (up 13.86% YoY), while the FY2025 annual figure was $209.5 million, up 15.44% from the prior year.
• Assets was $191.9 million for Q1 2026 at Protara Therapeutics, down from $209.5 million in the prior quarter.
• In the past five years, Assets ranged from a high of $209.5 million in Q4 2025 to a low of $68.1 million in Q1 2024.
• Historically, Assets has averaged $133.2 million across 5 years, with a median of $144.6 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Assets tumbled 40.46% in 2023, then soared 147.39% in 2025.
• A 5-year view of Assets shows it stood at $113.3 million in 2022, then tumbled by 30.31% to $79.0 million in 2023, then jumped by 129.82% to $181.5 million in 2024, then gained by 15.44% to $209.5 million in 2025, then fell by 8.38% to $191.9 million in 2026.
• The last three Assets figures came in at $191.9 million (Q1 2026), $209.5 million (Q4 2025), and $144.6 million (Q3 2025), per Business Quant data.